Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ) Covered Calls

Jazz Pharmaceuticals plc - Ordinary Shares covered calls A specialty pharmaceutical company, which is focused on developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

You can sell covered calls on Jazz Pharmaceuticals plc - Ordinary Shares to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for JAZZ (prices last updated Fri 4:16 PM ET):

Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
137.96 +1.91 135.00 145.46 975K 16 8.3
Covered Calls For Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Mar 21 140 1.35 144.11 -2.9% -132.3%
Apr 17 140 2.80 142.66 -1.9% -19.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded on January 18, 2012 and is headquartered in Dublin, Ireland.